Trial Profile
Prospective Randomized Trial to Compare a Twice Daily to a Once Daily Administration of the Tacrolimus in Lung Transplanted Patients.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 11 Oct 2013
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Lung transplant rejection
- Focus Therapeutic Use
- Acronyms Advagraf
- 21 Jul 2012 Actual initiation date (2 Jul 2012) added as reported by European Clinical Trials Database record.
- 02 Jul 2012 Status changed from not yet recruiting to discontinued as reported by European Clinical Trials Database record.
- 30 Jul 2009 Planned initiation date (Jul 2009) added as reported by ClinicalTrials.gov.